DK383874A - - Google Patents

Info

Publication number
DK383874A
DK383874A DK383874A DK383874A DK383874A DK 383874 A DK383874 A DK 383874A DK 383874 A DK383874 A DK 383874A DK 383874 A DK383874 A DK 383874A DK 383874 A DK383874 A DK 383874A
Authority
DK
Denmark
Application number
DK383874A
Other languages
Danish (da)
Other versions
DK144094B (da
DK144094C (da
Inventor
I Monkovic
Y Lambert
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK383874A publication Critical patent/DK383874A/da
Priority to DK206379A priority Critical patent/DK145464C/da
Publication of DK144094B publication Critical patent/DK144094B/da
Application granted granted Critical
Publication of DK144094C publication Critical patent/DK144094C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK383874A 1973-07-18 1974-07-17 Analogifremgangsmaade til fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner eller syreadditionssalte deraf DK144094C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK206379A DK145464C (da) 1973-07-18 1979-05-18 8-oxamorphinanderivater til anvendelse som mellemprodukter ved fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38051573 1973-07-18
US00380515A US3853889A (en) 1973-07-18 1973-07-18 3,14-substituted-8-oxamorphinans

Publications (3)

Publication Number Publication Date
DK383874A true DK383874A (de) 1975-03-03
DK144094B DK144094B (da) 1981-12-07
DK144094C DK144094C (da) 1982-05-10

Family

ID=23501468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK383874A DK144094C (da) 1973-07-18 1974-07-17 Analogifremgangsmaade til fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner eller syreadditionssalte deraf

Country Status (13)

Country Link
US (1) US3853889A (de)
JP (1) JPS5835197B2 (de)
BE (1) BE817755A (de)
CA (1) CA1029722A (de)
CH (2) CH605963A5 (de)
DE (1) DE2434687A1 (de)
DK (1) DK144094C (de)
FR (1) FR2311540A1 (de)
GB (1) GB1473896A (de)
NL (1) NL7409743A (de)
SE (1) SE422581B (de)
YU (2) YU37478B (de)
ZA (1) ZA744492B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959290A (en) * 1973-07-18 1976-05-25 Bristol-Myers Company 3,14-Substituted-8-oxamorphinans
US3957793A (en) * 1974-09-20 1976-05-18 Sterling Drug Inc. Hydroxyiminobenzazocines
US3968114A (en) * 1974-09-20 1976-07-06 Sterling Drug Inc. 1,2,3,4,5,6,7,8,9,10-Decahydro-8-oxo-2,6-methano-3-benzazocines
US4032529A (en) * 1974-09-20 1977-06-28 Sterling Drug Inc. Aminomethanobenzazocine intermediates
US4016167A (en) * 1975-10-28 1977-04-05 Bristol-Myers Company N-Substituted-6,8-dioxamorphinans
US4127577A (en) * 1975-11-24 1978-11-28 Sterling Drug Inc. Aminomethanobenzazocine process
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
US4154932A (en) * 1977-09-08 1979-05-15 Bristol-Myers Company 6-Oxamorphinans
US4150032A (en) * 1978-01-18 1979-04-17 Bristol-Myers Company 9-Oxobenzomorphan process and intermediates
WO1980000566A1 (en) * 1978-09-12 1980-04-03 Bristol Myers Co N-substituted-6-oxamorphinans
US4234731A (en) * 1979-01-05 1980-11-18 Bristol-Myers Company 9-Oxobenzomorphan process
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4246413A (en) * 1979-05-14 1981-01-20 Bristol-Myers Company 6-Oxamorphinans
US4277605A (en) * 1980-03-07 1981-07-07 Bristol-Myers Company Chemical compounds
AU2003298691A1 (en) * 2002-11-18 2004-06-15 The Mclean Hospital Corporation Mixed kappa/mu opioids and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639407A (en) * 1965-05-05 1972-02-01 Geigy Chem Corp Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
US3476757A (en) * 1966-04-18 1969-11-04 Syntex Corp Tetrahydropyranyl and tetrahydrofuranyl ethers of benzomorphans and morphanans
US3480638A (en) * 1966-11-10 1969-11-25 Geigy Chem Corp Derivatives of 5-hydroxyalkyl-6,7-benzomorphans
US3632591A (en) * 1968-07-19 1972-01-04 Sterling Drug Inc 1 2 3 4 5 6 - hexahydro-3-(cycloaliphatic or cycloaliphatic 11-dimethyl-2 alkyl)-66-methano-3-benzazocines
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation
US3732233A (en) * 1970-07-23 1973-05-08 Beecham Group Ltd Tetrahydromethano benzoxazocins and salts thereof

Also Published As

Publication number Publication date
CA1029722A (en) 1978-04-18
DE2434687A1 (de) 1975-02-06
US3853889A (en) 1974-12-10
NL7409743A (nl) 1975-01-21
ZA744492B (en) 1975-07-30
YU201674A (en) 1982-06-18
AU7137574A (en) 1976-01-22
CH605963A5 (de) 1978-10-13
DK144094B (da) 1981-12-07
YU37346B (en) 1984-08-31
DK144094C (da) 1982-05-10
YU324080A (en) 1983-04-27
FR2311540B1 (de) 1979-05-18
CH605962A5 (de) 1978-10-13
SE422581B (sv) 1982-03-15
SE7409253L (de) 1975-01-20
FR2311540A1 (fr) 1976-12-17
BE817755A (fr) 1975-01-17
JPS5835197B2 (ja) 1983-08-01
JPS5048000A (de) 1975-04-28
GB1473896A (en) 1977-05-18
YU37478B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AU476761B2 (de)
AU465372B2 (de)
AR201235Q (de)
AR201231Q (de)
AU474593B2 (de)
AU474511B2 (de)
AU474838B2 (de)
AU471343B2 (de)
AU465453B2 (de)
FR2311540B1 (de)
AU465434B2 (de)
AU450229B2 (de)
AU476714B2 (de)
AR201229Q (de)
AU472848B2 (de)
AU466283B2 (de)
AU476696B2 (de)
AR199451A1 (de)
AU477823B2 (de)
AR196382A1 (de)
AU476873B1 (de)
AU447540B2 (de)
AR210729A1 (de)
AU461342B2 (de)